Overview

First Time in Man Study of Finafloxacin Hydrochloride

Status:
Completed
Trial end date:
2008-05-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to study the safety of single doses and multiple doses of Finafloxacin hydrochloride in healthy volunteers. The level of Finafloxacin hydrochloride will be measured in the subjects blood and urine. One part of the study will assess if Finafloxacin hydrochloride eradicates Helicobacter pylori, a stomach bacteria. Another part of the study will assess the activity of the drug in urine.
Phase:
Phase 1
Details
Lead Sponsor:
MerLion Pharmaceuticals GmbH
Treatments:
Finafloxacin
Fluoroquinolones